Syneron Medical Appoints William Griffing to Newly Created Position of CEO of Syneron Candela North America

Syneron Medical Ltd. appointed William Griffing to the newly created position of Chief Executive Officer of Syneron Candela North America, effective immediately. In this position, Mr. Griffing will be responsible for aligning and managing the Company's growth strategies for its North American business, with direct responsibility for sales, marketing, clinical education and customer service, all of which will report directly to him and to the relevant corporate managers. Mr. Griffing will also be part of Syneron's global management team.

Prior to joining Syneron, Mr. Griffing served as Vice President and General Manager of Bayer Healthcare's US Dermatology business. Mr. Griffing also served as President and Chief Executive Officer of Intendis Inc., the predecessor business to the Bayer Healthcare US Dermatology business. Before his time at Bayer, Mr. Griffing spent more than 20 years at Merck & Co. in various sales and marketing leadership positions, most recently as a General Manager in their Global Human Health business.

Amit Meridor, Chief Executive Officer of Syneron Medical, said, "We are very pleased to welcome Bill Griffing as the CEO of our North American business. Bill has exceptional experience leading large pharmaceutical businesses that included building and maintaining long-term relationships with physicians, physician office staff, and consumers. We believe this puts him in an excellent position to work with our existing team to execute on growth strategies, in particular transforming our business to a partnership culture with our customers."

The company will have three divisions in North America, including the Aesthetic Division, Body Division, and CoolTouch Division, with separate sales organizations that will focus on these specific areas of the market. The following executives will lead these divisions and report directly to Mr. Griffing: Erik Dowell will continue in his role as President of North America leading the Company's North American Aesthetic Division. Brian Hayes will continue in his role as Vice President, Body Division, leading the Company's North American Body Division. Ilan Ben David will continue to lead the Company's CoolTouch Division.

Mr. Meridor concluded, "I am confident that with Bill, Erik, Brian and Ilan leading our North American team, we have a strong combination of experience and appropriate focus to execute on our growth strategies. Each of our Division leaders and their teams will benefit from Bill's guidance and experience as we strive to meet the specific needs of our customers in each of these areas of the market and forge strong, long-term relationships with our customers."

Mr. Griffing commented, "I am very excited to assume this newly created role of CEO, North America at Syneron Candela and I am looking forward to leveraging my experiences to drive the growth of the business while building stronger customer relationships."